Literature DB >> 19512959

Cytochrome P450 2D6.

Ryan P Owen1, Katrin Sangkuhl, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19512959      PMCID： PMC4373606          DOI： 10.1097/FPC.0b013e32832e0e97

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  30 in total

Review 1.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  Nomenclature for human CYP2D6 alleles.

Authors:  A K Daly; J Brockmöller; F Broly; M Eichelbaum; W E Evans; F J Gonzalez; J D Huang; J R Idle; M Ingelman-Sundberg; T Ishizaki; E Jacqz-Aigrain; U A Meyer; D W Nebert; V M Steen; C R Wolf; U M Zanger
Journal:  Pharmacogenetics       Date:  1996-06

3.  A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity.

Authors:  C Masimirembwa; I Persson; L Bertilsson; J Hasler; M Ingelman-Sundberg
Journal:  Br J Clin Pharmacol       Date:  1996-12       Impact factor: 4.335

4.  Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.

Authors:  M Eichelbaum; M P Baur; H J Dengler; B O Osikowska-Evers; G Tieves; C Zekorn; C Rittner
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

5.  Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon.

Authors:  B Evert; E U Griese; M Eichelbaum
Journal:  Pharmacogenetics       Date:  1994-10

6.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

7.  Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.

Authors:  F J Gonzalez; F Vilbois; J P Hardwick; O W McBride; D W Nebert; H V Gelboin; U A Meyer
Journal:  Genomics       Date:  1988-02       Impact factor: 5.736

8.  A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects.

Authors:  Sebastian Raimundo; Claudia Toscano; Kathrin Klein; Joachim Fischer; Ernst-Ulrich Griese; Michel Eichelbaum; Matthias Schwab; Ulrich M Zanger
Journal:  Clin Pharmacol Ther       Date:  2004-08       Impact factor: 6.875

9.  Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.

Authors:  R Saxena; G L Shaw; M V Relling; J N Frame; D T Moir; W E Evans; N Caporaso; B Weiffenbach
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

Review 10.  PM frequencies of major CYPs in Asians and Caucasians.

Authors:  Takaharu Mizutani
Journal:  Drug Metab Rev       Date:  2003 May-Aug       Impact factor: 4.518
View more
  51 in total

1.  Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects.

Authors:  Ophelia Qi Ping Yin; Valiant Wah Lun Mak; Miao Hu; Benny Siu Pong Fok; Moses Sing Sum Chow; Brian Tomlinson
Journal:  Eur J Clin Pharmacol       Date:  2012-01-27       Impact factor: 2.953

2.  Pharmacogenomics and bioinformatics: PharmGKB.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

3.  Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.

Authors:  Wanqiong Qiao; Suparna Martis; Geetu Mendiratta; Lisong Shi; Mariana R Botton; Yao Yang; Andrea Gaedigk; Raymon Vijzelaar; Lisa Edelmann; Ruth Kornreich; Robert J Desnick; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2018-12-06       Impact factor: 2.533

4.  Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis.

Authors:  Annelies C Ham; Suzanne C van Dijk; Karin M A Swart; Anke W Enneman; Nikita L van der Zwaluw; Elske M Brouwer-Brolsma; Natasja M van Schoor; M Carola Zillikens; Paul Lips; Lisette C P G M de Groot; Albert Hofman; Renger F Witkamp; André G Uitterlinden; Bruno H Stricker; Nathalie van der Velde
Journal:  Br J Clin Pharmacol       Date:  2017-07-04       Impact factor: 4.335

Review 5.  Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.

Authors:  Yao Yang; Mariana R Botton; Erick R Scott; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2017-05-04       Impact factor: 2.533

Review 6.  Genetics of perioperative pain management.

Authors:  Senthil Packiasabapathy; Nicole Horn; Senthilkumar Sadhasivam
Journal:  Curr Opin Anaesthesiol       Date:  2018-12       Impact factor: 2.706

7.  A physiome interoperability roadmap for personalized drug development.

Authors:  Simon Thomas; Katherine Wolstencroft; Bernard de Bono; Peter J Hunter
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

Review 8.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

Review 9.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

10.  The CYP2D6 VCF Translator.

Authors:  W Qiao; J Wang; B S Pullman; R Chen; Y Yang; S A Scott
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.